Valuation (14%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -16.20 | -22.08 |
PEG Ratio (TTM) | 10.26 | 15.66 |
P/S Ratio (TTM) | 2,948.81 | 49.38 |
P/B Ratio (TTM) | 8.11 | 18.85 |
P/FCF Ratio (TTM) | -18.16 | -3.07 |
Price to 5YR AVG Earnings Ratio | -19.42 | -3.42 |
Price to 5YR AVG FCF Ratio | -34.22 | -9.04 |
Profitability (25%) |
Company | Industry |
---|---|---|
ROA (TTM) | -46.22% | -5.15% |
ROE (TTM) | -52.07% | 16.37% |
Net Profit Margin (TTM) | -18,169.93% | -2,030.32% |
ROIC 5YR AVG | 1,340.66% | 15.65% |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -4.69% | -5.27% | -9.07% |
Revenue | -25.00% | N/A | N/A |
Net Income | -7.30% | -77,380.57% | -46,439.85% |
Cash Flow | -14.90% | -62,297.61% | -37,396.80% |
Health (63%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 13.08 | 6.19 |
Quick Ratio (TTM) | 13.08 | 5.91 |
D/E Ratio (TTM) | 0.00 | -15.10 |
Interest Coverage (TTM) | N/A | -1.60 |
Piotroski F-Score | 3 | 5 |
Altman Z-Score | 56.37 | 14.02 |
LTL to 5YR AVG FCF | N/A | 0.18 |
Shares Outstanding Growth 5YR AVG | 38,981.36% | 123.85% |